CN109310722A - 用于预防弧菌感染的方法和组合物 - Google Patents

用于预防弧菌感染的方法和组合物 Download PDF

Info

Publication number
CN109310722A
CN109310722A CN201780033655.0A CN201780033655A CN109310722A CN 109310722 A CN109310722 A CN 109310722A CN 201780033655 A CN201780033655 A CN 201780033655A CN 109310722 A CN109310722 A CN 109310722A
Authority
CN
China
Prior art keywords
vibrio
bacteriophage
composition
icp
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780033655.0A
Other languages
English (en)
Chinese (zh)
Inventor
A·卡米利
L·凯恩斯
颜珉珉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts University
Original Assignee
TUFTS MED, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TUFTS MED, University of filed Critical TUFTS MED, University of
Publication of CN109310722A publication Critical patent/CN109310722A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201780033655.0A 2016-04-01 2017-03-31 用于预防弧菌感染的方法和组合物 Pending CN109310722A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662316704P 2016-04-01 2016-04-01
US62/316,704 2016-04-01
PCT/US2017/025305 WO2017173229A1 (en) 2016-04-01 2017-03-31 Methods and compositions for preventing infection by a vibrio species

Publications (1)

Publication Number Publication Date
CN109310722A true CN109310722A (zh) 2019-02-05

Family

ID=59966476

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780033655.0A Pending CN109310722A (zh) 2016-04-01 2017-03-31 用于预防弧菌感染的方法和组合物

Country Status (7)

Country Link
US (1) US10953053B2 (enExample)
EP (1) EP3436611A4 (enExample)
JP (1) JP2019510052A (enExample)
KR (4) KR20220138015A (enExample)
CN (1) CN109310722A (enExample)
CA (1) CA3026327A1 (enExample)
WO (1) WO2017173229A1 (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110352880A (zh) * 2019-08-13 2019-10-22 宁波大学 一种紫菜黄斑病的治疗方法
CN111826309A (zh) * 2020-06-30 2020-10-27 武汉合缘绿色生物股份有限公司 一种液体生物营养菌剂及其制备方法
CN112391358A (zh) * 2019-08-14 2021-02-23 宁波大学 地中海弧菌烈性噬菌体vB_VmeM-Yong及其应用
CN112553171A (zh) * 2020-12-27 2021-03-26 威海长青海洋科技股份有限公司 一种弧菌噬菌体制剂及其应用
CN112646786A (zh) * 2021-01-21 2021-04-13 海南海壹水产种苗有限公司 一株坎式弧菌噬菌体快速初步分离方法
CN114774371A (zh) * 2022-06-21 2022-07-22 中国海洋大学 一种弧菌噬菌体及其应用
CN116103183A (zh) * 2022-03-30 2023-05-12 山东科技大学 一株脱除高盐硬水中钙离子的巨大弧菌及其应用
CN120058874A (zh) * 2025-04-29 2025-05-30 中国疾病预防控制中心传染病预防控制所 噬菌体蛋白Gp37及其在制备抑制霍乱弧菌定植和毒素分泌的制剂中的应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
CN107904212A (zh) * 2017-10-13 2018-04-13 深圳先进技术研究院 溶藻弧菌噬菌体及包含该噬菌体的杀菌组合物
CN107904213A (zh) * 2017-10-13 2018-04-13 深圳先进技术研究院 溶藻弧菌噬菌体及包含该噬菌体的杀菌组合物
CN107904214A (zh) * 2017-10-13 2018-04-13 深圳先进技术研究院 溶藻弧菌噬菌体及包含该噬菌体的杀菌组合物
CN107904211B (zh) * 2017-10-13 2024-03-19 深圳先进技术研究院 副溶血弧菌噬菌体及包含该噬菌体的杀菌组合物
CN107805630B (zh) * 2017-10-13 2024-03-19 深圳先进技术研究院 副溶血弧菌噬菌体及包含该噬菌体的杀菌组合物
CN107805629B (zh) * 2017-10-13 2023-03-21 深圳先进技术研究院 溶藻弧菌噬菌体及包含该噬菌体的杀菌组合物
CN108048412A (zh) * 2017-11-20 2018-05-18 深圳先进技术研究院 裂性弧菌噬菌体ValLY-4及包含该噬菌体的杀菌组合物及其应用
CN107988171A (zh) * 2017-11-20 2018-05-04 深圳先进技术研究院 裂性弧菌噬菌体ValSw4-1及包含该噬菌体的杀菌组合物及其应用
CN107988172A (zh) * 2017-11-20 2018-05-04 深圳先进技术研究院 裂性弧菌噬菌体VpaJT-1及包含该噬菌体的杀菌组合物及其应用
CN108048410B (zh) * 2017-11-20 2023-06-27 深圳先进技术研究院 裂性弧菌噬菌体VspSw-1及包含该噬菌体的杀菌组合物及其应用
CN108048409A (zh) * 2017-11-20 2018-05-18 深圳先进技术研究院 裂性弧菌噬菌体ValLY-3及包含该噬菌体的杀菌组合物及其应用
CN108048411A (zh) * 2017-11-20 2018-05-18 深圳先进技术研究院 裂性弧菌噬菌体ValLY-2及包含该噬菌体的杀菌组合物及其应用
CN108070570A (zh) * 2017-11-20 2018-05-25 深圳先进技术研究院 裂性弧菌噬菌体ValDsh-1及包含该噬菌体的杀菌组合物及其应用
JP6923862B2 (ja) * 2018-05-22 2021-08-25 学校法人自治医科大学 抗菌ファージ、治療用組成物、殺菌剤、食品、細菌判別キット、治療用組成物製造方法、細菌除去方法、細菌判別方法、及び動物治療方法
CN109517804B (zh) * 2018-11-19 2022-06-14 扬州大学 一种具有跨种裂解特性的拟态弧菌噬菌体oy-1、制备方法及其应用
CN112029733B (zh) * 2020-09-24 2021-11-26 瑞科盟(青岛)生物工程有限公司 一株高裂解性溶藻弧菌噬菌体rdp-vp-19001及其应用
CN112011520B (zh) * 2020-10-30 2021-01-19 中国科学院南海海洋研究所 一种调控珊瑚菌群的温和噬菌体VneM1及其应用
CN113201505B (zh) * 2021-04-02 2023-12-29 青岛诺安百特生物技术有限公司 一株具备跨种裂解能力的溶藻弧菌噬菌体、其噬菌体组合物及其应用
KR102774411B1 (ko) * 2021-10-27 2025-02-27 전북대학교산학협력단 재증식 풀 컬쳐 기반 박테리오파지 스크리닝 방법
CN115820569B (zh) * 2022-08-09 2025-01-14 青岛诺安百特生物技术有限公司 一株奥氏弧菌噬菌体、其噬菌体组合物及其应用
KR20240058217A (ko) 2022-10-25 2024-05-03 주식회사 엘지에너지솔루션 고분자 고체 전해질 및 이의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140105866A1 (en) * 2012-10-17 2014-04-17 Universidad De Chile Bacteriophages useful for the prophylaxis and therapy of vibrio anguillarum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755441A4 (en) 1994-04-05 2000-01-26 Exponential Biotherapies Inc Antibacterial therapy with genotypically modified bacteriophage
EP1250050B1 (en) 2000-01-11 2004-10-27 Intralytix Inc. Method and device for sanitation using bacteriophages
US8956628B2 (en) 2007-12-13 2015-02-17 Zoetis Products Llc Bacteriophage preparations and method of use thereof
US9839657B2 (en) * 2012-10-30 2017-12-12 Deerland Enzymes, Inc. Prebiotic compositions comprising one or more types of bacteriophage
US10760065B2 (en) * 2013-09-05 2020-09-01 Massachusetts Institute Of Technology Tuning microbial populations with programmable nucleases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140105866A1 (en) * 2012-10-17 2014-04-17 Universidad De Chile Bacteriophages useful for the prophylaxis and therapy of vibrio anguillarum

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABHISHEK JAISWAL 等: "Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice", 《INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY》 *
ABHISHEK JAISWAL 等: "Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model", 《MICROBES AND INFECTION》 *
SEED, KD 等: "Evidence of a Dominant Lineage of Vibrio cholerae-Specific Lytic Bacteriophages Shed by Cholera Patients over a 10-Year Period in Dhaka, Bangladesh", 《MBIO》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110352880A (zh) * 2019-08-13 2019-10-22 宁波大学 一种紫菜黄斑病的治疗方法
CN110352880B (zh) * 2019-08-13 2021-04-20 宁波大学 一种紫菜黄斑病的治疗方法
CN112391358A (zh) * 2019-08-14 2021-02-23 宁波大学 地中海弧菌烈性噬菌体vB_VmeM-Yong及其应用
CN112391358B (zh) * 2019-08-14 2023-12-01 宁波大学 地中海弧菌烈性噬菌体vB_VmeM-Yong及其应用
CN111826309A (zh) * 2020-06-30 2020-10-27 武汉合缘绿色生物股份有限公司 一种液体生物营养菌剂及其制备方法
CN112553171A (zh) * 2020-12-27 2021-03-26 威海长青海洋科技股份有限公司 一种弧菌噬菌体制剂及其应用
CN112646786A (zh) * 2021-01-21 2021-04-13 海南海壹水产种苗有限公司 一株坎式弧菌噬菌体快速初步分离方法
CN116103183A (zh) * 2022-03-30 2023-05-12 山东科技大学 一株脱除高盐硬水中钙离子的巨大弧菌及其应用
CN114774371A (zh) * 2022-06-21 2022-07-22 中国海洋大学 一种弧菌噬菌体及其应用
CN114774371B (zh) * 2022-06-21 2022-09-13 中国海洋大学 一种弧菌噬菌体及其应用
CN120058874A (zh) * 2025-04-29 2025-05-30 中国疾病预防控制中心传染病预防控制所 噬菌体蛋白Gp37及其在制备抑制霍乱弧菌定植和毒素分泌的制剂中的应用
CN120058874B (zh) * 2025-04-29 2025-09-09 中国疾病预防控制中心传染病预防控制所 噬菌体蛋白Gp37及其在制备抑制霍乱弧菌定植和毒素分泌的制剂中的应用

Also Published As

Publication number Publication date
KR20220138015A (ko) 2022-10-12
EP3436611A4 (en) 2019-11-06
KR102755264B1 (ko) 2025-01-21
KR20240005101A (ko) 2024-01-11
JP2019510052A (ja) 2019-04-11
KR20190005846A (ko) 2019-01-16
US20190099459A1 (en) 2019-04-04
KR20230132886A (ko) 2023-09-18
CA3026327A1 (en) 2017-10-05
WO2017173229A1 (en) 2017-10-05
EP3436611A1 (en) 2019-02-06
US10953053B2 (en) 2021-03-23

Similar Documents

Publication Publication Date Title
CN109310722A (zh) 用于预防弧菌感染的方法和组合物
Sumithra et al. Pathological investigations of Vibrio vulnificus infection in genetically improved farmed tilapia (Oreochromis niloticus L.) cultured at a floating cage farm of India
Cheikh et al. First evidence for a Vibrio strain pathogenic to Mytilus edulis altering hemocyte immune capacities
KR101335825B1 (ko) 신규 박테리오파지 및 이를 포함하는 항균 조성물
de Oliveira et al. Recurrent Streptoccoccus agalactiae infection in Nile tilapia (Oreochromis niloticus) treated with florfenicol
Didinen et al. Identification and characterization of lactic acid bacteria isolated from rainbow trout (Oncorhynchus mykiss, Walbaum 1792), with inhibitory activity against Vagococcus salmoninarum and Lactococcus garvieae
CN116249764B (zh) 用作益生菌的细菌菌株、其组合物、保藏菌株和鉴定益生菌细菌菌株的方法
Wei et al. Isolation and characterization of Vibrio harveyi as a major pathogen associated with mass mortalities of ark clam, Scapharca broughtonii, in summer
Nicolas et al. In ovo administration of a phage cocktail partially prevents colibacillosis in chicks
CN107099511A (zh) 一株具有鼠伤寒沙门氏菌防治效果的噬菌体及其应用
Toukam et al. In vivo antimalarial activity of a probiotic bacterium Lactobacillus sakei isolated from traditionally fermented milk in BALB/c mice infected with Plasmodium berghei ANKA
Abdallah et al. Isolation and characterization of Streptococcus agalactiae inducing mass mortalities in cultured Nile tilapia (Oreochromis niloticus) with trials for disease control using zinc oxide nanoparticles and ethanolic leaf extracts of some medicinal plants
Kunttu Characterizing the bacterial fish pathogen Flavobacterium columnare, and some factors affecting its pathogenicity
Chanthavong et al. Effectiveness of a single-dose phage cocktail on the reduction of multidrug-resistant Escherichia coli in suckling piglets
Shazwani et al. Evaluation of Antagonism Activity of Potential Malaysian Probiont Strains, Bacillus spp. JAQ04 and Micrococcus spp. JAQ07 in in vitro Condition and on Artemia fransisca against Vibrio alginolyticus
Strand Analyses of bacteriophages to Yersinia ruckeri and the salmon (Salmo salar L.) antibody response to the bacteriophages
Jumaniyazova et al. Isolation and characterization of a novel Salmonella polyvalent bacteriophage ‘MediPhag’in Uzbekistan
Younus et al. Pathology and public health significance of Salmonella
Ulrich Impact of bacteriophages and nutrient environment on the metaorganism Hydra vulgaris AEP
Huff et al. Pathogenicity of Listeria monocytogenes Scott A after oral and oculonasal challenges of day-old turkey poults
Cole Assessing the Efficacy of a Bacteriophage Cocktail, Comprised of Three Monophages, Against Campylobacter spp. in Broiler Chickens
Zhao et al. Isolation and identification of the pathogen in a case of Takifugu rubripes coinfected with parasites and bacteria
Parent Strategies to reduce the use of antibiotics in commercial broiler chickens: impacts on growth performance, intestinal health and microbiota
Kunselman Microbiome Dynamics and Pathogen-Driven Impacts in Marine Mollusks: Insights from Oysters and White Abalone
Ribeiro Novel phage-derived product to control Paenibacillus larvae in bee hives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220811

Address after: Massachusetts

Applicant after: Trustees of Tufts College

Address before: Massachusetts

Applicant before: TUFTS University

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20190205

RJ01 Rejection of invention patent application after publication